The authors examined The National Cancer Database for patients who refused recommended surgery and elected stereotactic body radiation therapy (SBRT) for stage I/II non-small cell lung cancer.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer
July 10, 2020
Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice
June 27, 2020
The previous randomized study of minimally invasive esophagectomy vs open esophagectomy (TIME trial) conducted in the Netherlands demonstrated reduced pulmonary complications and LOS with MIE. Compared to the benefits of MIE in those selected high volume centers, national use of MIE was associated with increased overall complications, increased pulm
June 23, 2020
This video demonstrates the resection and replacement of the superior vena cava (SVC) and left innominate vein for the surgical treatment of a large invasive thymoma.
June 5, 2020
The authors compared surgically managed signet ring cell adenocarcinoma and esophageal adenocarcinoma patients in the National Cancer Database.
Complex Sleeve Lobectomy Has the Same Surgical Outcome When Compared With Conventional Lobectomy in Patients With Lung Cancer
May 8, 2020
This original article compares the outcome of sleeve lobectomy compared to conventional lobectomy in the treatment of patients with lung cancer. Inci et al. investigated 187 patients who underwent sleeve lobectomy and compared it to 568 patients who underwent conventional lobectomy.
May 6, 2020
The authors discuss the case of a 32-year-old man who was referred with a diagnosis of an extragonadal germ cell tumor in the anterior mediastinum.
April 27, 2020
This manuscript outlines the difficulties of providing safe thoracic surgery during COVID-19 and details solutions for overcoming these challenges.
Prognostic Factors Related to Postoperative Survival in the Newly Classified Clinical T4 Lung Cancer
April 21, 2020
This manuscript by Yamanashi et al retrospectively looks into the outcome of patients with newly classified clinical T4 lung cancer. They report 93 patients who underwent surgical treatment during a 10-year study period.
April 13, 2020
Topical review on the epidemic in Britain, with a number of observations that relate to the cardiothoracic surgeons and all healthcare professionals: -The assertion that the National Health Service in Britain was overrun PRIOR to the pandemic. -The assertion that acute angina is now being undertreated.
April 10, 2020
The NCDB was queried to assess the optimal timing for resection after induction therapy for IIIA NSCLC. Survival was better in patients who underwent surgery in a short delay interval (<77 days) compared to a long delay (>114 days); short and medium delay intervals had similar outcomes.